CORDIS
EU research results

CORDIS
English EN

European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan

Project information

Grant agreement ID: 825715

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2020

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 2 994 560

  • EU contribution

    € 2 994 560

Coordinated by:

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

Objective

Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.

Field of Science

/medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance

/medical and health sciences/health sciences/infectious diseases

/social sciences/economics and business

/social sciences/sociology/governance

/social sciences/economics and business/business and management/business model

Programme(s)

H2020-EU.3.1.6. - Health care provision and integrated care

Topic(s)

SC1-HCO-08-2018 - Creation of a European wide sustainable clinical research network for infectious diseases

Call for proposal

H2020-SC1-2018-Single-Stage-RTD

See other projects for this call

Funding Scheme

CSA - Coordination and support action
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Address

Heidelberglaan 100
3584 Cx Utrecht

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 257 735

Website

Contact the organisation

Participants (12)

UNIVERSITEIT ANTWERPEN

Belgium

EU Contribution

€ 271 350

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK

France

EU Contribution

€ 265 150

FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS

Italy

EU Contribution

€ 165 150

UMEA UNIVERSITET

Sweden

EU Contribution

€ 79 425

UNIVERSITE D'AIX MARSEILLE

France

EU Contribution

€ 163 275

DANMARKS TEKNISKE UNIVERSITET

Denmark

EU Contribution

€ 83 850

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 158 850

ROBERT KOCH-INSTITUT

Germany

EU Contribution

€ 79 425

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS

Belgium

EU Contribution

€ 79 425

ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

Italy

EU Contribution

€ 83 850

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 215 150

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 91 925

Project information

Grant agreement ID: 825715

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2020

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 2 994 560

  • EU contribution

    € 2 994 560

Coordinated by:

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

Download

PDF XML

Last update: 29 July 2019

Record number: 221649